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Background. The aim of this study was to investigate patient outcomes and nutritional deﬁciencies following sleeve gastrectomy
(SG) during a follow-up of two years. Methods. Over a period of 56 months, all consecutive patients who underwent SG were
documented in this prospective, single-center, observational study. The study endpoints included operative time, complication
rates, nutritional deﬁciencies and percentage of excess weight loss (%EWL). Results. From September 26, 2005 to May 28, 2009,
82 patients (female:male = 48:34) with a mean age of 43.3 years (range: 22–64) and a preoperative BMI of 52.5kg/m2 (range:
36.8–77.0) underwent SG. Major complications were observed in 9.8% of the patients, with 1 death. During follow up 51.2% of
patients were supplemented with iron, 36.6% with zinc, 37.8% with calcium, 26.8% with vitamin D, 46.3% with vitamin B12 and
41.5% with folic acid. %EWL was 54.3, 65.3 and 62.6% after 6, 12 and 24 months. Conclusion. SG as a single step procedure is an
eﬀective bariatric intervention. Nutritional deﬁciencies after SG can be detected by routine nutritional screening. Our results show
that Vitamin B12 supplementation should suggest routinely after SG.
1.Introduction
Obesity has developed an epidemic way. Approximately 1.7
billion people are overweight, and 312 million are obese
[1, 2]. In Germany in 2009, 60.1% of male and 42.9% of
femalepopulationwasoverweight[3].Therearecurrentlyno
conservative treatments having long-term eﬀect on weight
loss and amelioration of comorbidities.
Obesity is associated with an increased mortality risk
[4]. Obesity is also associated with increased health costs. A
BMI ≥ 35kg/m2 is associated with a 200% increase in health
care costs compared to the normal weight range [5]. An
indicationforbariatricsurgeryisaBMI ≥40kg/m2 oraBMI
≥ 35 kg/m2 accompanied by obesity-associated diseases.
As a result of new technologies with lower risks and
better long-term results, bariatric and metabolic surgeries
h a v eg r o w ni np o p u l a r i t yi nr e c e n ty e a r s .T h en u m b e ro f
operations performed is rapidly increasing. After the Magen-
strasse and Mill procedure, laparoscopic sleeve gastrectomy
was performed as the single-step procedure for surgically
induced weight loss in 2000 [6].
Two-stage procedures are especially necessary for multi
morbid patients with BMI above 50kg/m2 due to the rising
risks of RYGBP or duodenal switch (DS).
Considering the high mortality rate of 6% following
biliopancreatic diversion (BPD) with DS, SG is to be
preferred as a ﬁrst-step operation for these patients [7, 8].
The aim of this systematic study was to investigate
nutritional deﬁciencies and outcomes following sleeve gas-
trectomy during a followup of two years in the daily routine
of a maximal clinical care hospital.
2. Patients andMethods
From September 26, 2005 to May 28, 2009, 82 patients
underwent sleeve gastrectomies in the Department of
Surgery of the SRH Wald-Klinikum Gera Hospital.
After we ensured compliance with international and
German guidelines [9, 10] and excluded endocrine causes of
obesity, the patient participated in an informational seminar
and was evaluated by experienced bariatric surgeons, and SG
was performed.2 Journal of Obesity
Table 1: Recorded parameters.
Age OP duration
Sex Use of staple line reinforcement
Hospitalization Bougie size








All medical data were collected prospectively and
analyzed retrospectively. Patients were classiﬁed according
to the WHO classiﬁcations of obesity (35–39.9kg/m2;
40–49.9kg/m2) with expansions to “super obesity” (50–
59.9kg/m2) and “super-super obesity” (≥60 kg/m2).
The evaluated parameters were recorded and are listed in
Table 1.
Acute and postoperative complications, as well as
their treatments, were evaluated. Acute complications were
deﬁned as intervention-associated or intraoperative compli-
cations.
2.1. Sleeve Gastrectomy: Operation Technique. SG was per-
formedintheFrenchpositionina30◦ reverse Trendelenburg
position. The surgeon stood between the patient’s legs with
assistants on both sides.
Pneumoperitoneum was established to 15mmHg using
a Veress needle (the alternative open technique). The ﬁrst
trocar for placing the camera was inserted 15cm distal to
the xiphoid process, and the abdominal cavity was reﬂected
outwards. Another trocar was placed on the epigastric angle,
and the liver was retracted superiorly using a fan retractor.
Two trocars were then placed on the right and left upper
quadrants.
The dissection of the greater curve and the division of
theshortgastricvesselsbegan5-6cmproximaltothepylorus
and extended to the angle of His.
The sleeve was created via a trocar incision at the
right upper quadrant. Sleeve resection of the stomach was
performed using an Endo GIA stapler (green) made by
Covidien, Germany.
A bougie size 31–36Fr was inserted transorally and
guided along the lesser curvature toward the antrum of the
stomach.Thesleeveresectionwascontinuedusingstapleline
reinforcement along the length of the bougie to the angle of
His. Over sewing of staple line was not performed due to the
use of staple line reinforcement.
At that point, approximately 75–80% of the stomach was
separated. The bougie was removed after the application of
methylene blue to inspect for leaks along the staple line.
T h er e s e c t e ds t o m a c hw a sp l a c e di nar e t r i e v a lb a ga n d
removed by enlarging the trocar incision at the upper right
quadrant.
Aftercheckingforpossiblefurtherintraabdominalbleed-
ing, a silicone drain was placed.
The trocar was removed under direct visualization, and
the abdomen was deﬂated. The fascial defect was closed, and
a sterile surgical dressing was set.
At the end of the surgery, the resected stomach was
ﬁlled with water to determine the volume of the resection.
Histopathological analysis was then performed on the speci-
men.
2.2. DVT Prophylaxis. DVT prophylaxis was performed in
all patients. Besides antithrombotic stockings we used low
molecular weight heparin (NMH) at least 21 days postop-
eratively. Only in patients with a length of stay in hospital
more than 21 days prophylaxis was performed further on. In
patientswithaweightover120kgNMHwasgivenonceaday
and over 120kg twice a day.
2.3. Antibiotics. In all patients a single-shot antibiosis was
given using a third-generation cephalosporin. If an intraop-
erative complication occurred antibiosis was continued.
2.4. Nutrition and Postoperative Diet. In all patients a
contrast swallow was performed at the ﬁrst postoperative
day. After contrast swallow patients were allowed to drink
250cc water or tea at the ﬁrst, 500cc at the second, 1000cc at
the third postoperative day. After the ﬁfth day we started for
a week with liquids and after the second postoperative week
patients could eat pulpy.
2.5. Postoperative Followup. All of the patients were exam-
ined throughout a 24-month follow-up period (at 3, 6, 12,
18,and24monthspostoperatively).Theinformationforthis
study came from patient records from the hospital and the
clinical outpatient department.
Furthermore, short- and long-term results with regard to
BMI, weight, %EWL, and important laboratory parameters
(iron, zinc, selenium, alkaline phosphatase, hemoglobin,
MCV, albumin, vitamin B12, folic acid, calcium, and
parathyroid hormone levels) were registered. Furthermore,
necessity of medical substitutions or second operations (DS
or RYGBP) had been evaluated.
3. Results
3.1. Demographic Data. From September 26, 2005 to May
28, 2009, 82 patients (sex ratio, females:males = 48:34
[1.4:1]) with a mean age of 43.3 years (range, 22–64)
and a preoperative BMI of 52.5kg/m2 (range, 36.8–77.0)
underwent sleeve gastrectomies. Operation was performed
by three diﬀerent surgeons, operating as a team in all the 82
recorded operations. Patient’s outcome and operation time
were not aﬀected by changing the surgeon in these teams.
SixpatientshadBMIsbetween35and39.9kg/m2,23had
BMIs between 40 and 49.9kg/m2,3 5h a dB M I sb e t w e e n5 0
and 59.9kg/m2, and 18 had BMIs over 60kg/m2. A total of
76.5% of the male patients and 56.3% of the females had
BMIs more than 50kg/m2.Journal of Obesity 3
Table 2: Data from patients and operations.
BMI
35–39.9kg/m2 40–49.9kg/m2 50–59.9kg/m2 ≥60kg/m2 Total
Sex
Male 4; 66.7% 4; 17.4% 18; 51.4% 8; 44.4% 34; 41.5%
Female 2; 33.3% 19; 82.6% 17; 48.6% 10; 55.6% 48; 58.5%
Age (years) 47.0 (33–64) 42.8 (22–59) 43.7 (22–58) 41.7 (25–59) 43.3 (22–64)
BMI (kg/m2) 36.8 (36.8–39.5) 44.3 (40.0–48.0) 53.6 (50.0–59.1) 65.6 (60.0–77.0) 52.5 (36.8–77.0)
Operation
Laparoscopy 6; 100.0% 22; 95.7% 33; 94.3% 14; 77.8% 75; 91.5%
Laparoscopy with conversion 1; 4.3% 1; 2.9% 4; 22.2% 6; 7.3%
Laparotomy 1; 2.9% 1; 1.2%
O p e r a t i v et i m e( m i n u t e s ) 75.3 (41–101) 73.7 (44–120) 95.1 (39–275) 102.0 (45–225) 89.3 (39–275)
Resected gastric volume (mL) 760.0 (650–900) 826.9 (600–1100) 1096.4 (500–1700) 1156.3 (750–1700) 1009.3 (500–1700)
Bougie size
31 French 1; 4.3% 1; 1.2%
32 French 1; 16.7% 1; 4.3% 2; 5.7% 1; 5.6% 5; 6.1%
34 French 4; 66.7% 21; 91.3% 31; 88.6% 17; 94.4% 73; 89.0%
36 French 1; 16.7% 2; 5.7% 3; 3.7%
Staple line reinforcement 5; 83.3% 22; 95.7% 29; 82.9% 14; 77,8% 70; 85.4%
3.2. Operation Data. Of the 82 patients, 81 underwent
primarily laparoscopic surgery. In 7.4% of these patients (6
of 81), a conversion from laparoscopy to laparotomy was
necessary. In one case, a primary laparotomy was performed
because of an abdominal wall hernia, resection of an anus
praeter, subtotal colectomy with an ileorectostomy and
known adhesions of the small intestine. Postoperative course
of the patient was uneventful.
The mean duration of the OP was 89.3min, and
the mean resected gastric volume was 1009.3mL. A 34Fr
calibration tube was used in 89% of the patients (73).
Staple line reinforcements were not available during our ﬁrst
cases. So they were used in 85.4% of the patients (Table 2).
Comparing leakage rate and bleeding in patients using staple
line reinforcement or over sewing was of no diﬀerence.
Thereweresigniﬁcantdiﬀerencesamongthedurationsof
theOP.Whenstaplelinereinforcementswereused,themean
OP duration was 80.7 minutes, compared to 141.4 minutes
without staple line reinforcements (P = 0.012).
A laparoscopy with conversion to laparotomy was per-
formed signiﬁcantly more often for patients with BMIs over
60kg/m2 compared to patients with lower BMIs (P = 0.02).
The duration of the OP averaged 75.3 minutes for
patients with BMIs between 35 and 39.9kg/m2, 73.7 minutes
for patients with BMIs between 40 and 49.9kg/m2, 95.1
minutes for patients with BMIs between 50 and 59.9kg/m2,
and102.0minutesforpatientswithBMIsover60kg/m2 (P<
0.001). Patients with BMIs over 50kg/m2 had signiﬁcantly
longer OP durations compared to patients with BMIs under
50kg/m2 (97.4 versus 74.0; P = 0.01).
The resected gastric volume was signiﬁcantly higher in
patients with BMIs over 50kg/m2 compared to patients with
BMIs under 50kg/m2 (1109.7 versus 808.3mL; P<0.0005).
3.3. Intraoperative and Early Postoperative Complications.
Twenty patients (24.4%) had intraoperative or/and post-
operative complications (Table 3). Out of the 82 patients,
81 were operated laparoscopically, and in 6 cases (7.4%),
a conversion to laparotomy was necessary. In 4 cases,
this conversion was performed because of an insuﬃcient
laparoscopic overview with high intraabdominal pressure.
In 2 cases, the conversion was because of laparoscopically
uncontrollable bleeding, which was related to an insuﬃcient
abdominal overview in 1 case.
Postoperative complications occurred in 17 patients
(20.7%). One patient died (1.2%). This patient had a
BMI of 55.5kg/m2, and on the tenth postoperative day,
he complained of left upper abdominal pain. The CT scan
showed an insuﬃcient suture with a subcardial abscess.
A CT-guided puncture ensued. Subsequently, to create an
internal drainage, a gastroscopy was performed, and during
this investigation, the patient aspirated. The patient’s cardiac
situation worsened, an ARDS developed, and the patient
died.
Acute complications have occurred signiﬁcantly more
frequently in patients with BMIs over 60kg/m2 (P<0.001).
Major complication rate was 9.8% (Table 4).
3.4. Follow-Up Data. Follow-up rate was 97.6% (80/82). All
of these patients were clinically examined with a laboratory
test 24 months after SG, so mean follow-up time is 24
months. The other 2 patients died during followup—1 of
them related due to a complication.
The mean preoperative BMI of all of the patients
examined was 52.5kg/m2. At the end of the followup, there
was a signiﬁcant reduction in BMI to 35.4kg/m2 (P<
0.0005). The greatest weight loss occurred within the ﬁrst4 Journal of Obesity
Table 3: Acute and postoperative complications.
Complications (20/82; 24.4%)
n Cause of acute complications/conversions (6/82; 7.3%) Postoperative complications (17/82; 20.7%)
1 Insuﬃcient intraabdominal view Abscess
2 Insuﬃcient intraabdominal view




4 Insuﬃcient intraabdominal view
5 Bleeding
6 Insuﬃcient intraabdominal view Bleeding Wound infection























18 Mild pulmonary edema
19 Pneumonia
20 Insuﬃcient wound healing
Table 4: Major complications (n = 8).
N Major complication
1 Bleeding
2 Iatrogenic perforation of duodenum
3 Bleeding + leakage + abscess
4 Leakage
5A b s c e s s
6 Leakage + abscess + ARDS with death
7 Severe wound infection with sepsis + thrombosis
8A b s c e s s
12 postoperative months (52.5kg/m2 to 36.7kg/m2), and
the loss gradually stabilized, with further weight loss from
36.7kg/m2 to 35.4kg/m2 for all of the patients examined
until now.
The %EWL in the BMI categories between 35 and
39.9kg/m2 and 40 and 49.9kg/m2 was 45.8% and 47.7%,
respectively, after 3 months. The greatest %EWL in these
categories was achieved after 18 (69.6% and 76.7%) months.
Both groups showed a slight tendency toward increased
weight after this time. Patients with BMIs between 50 and
59.9kg/m2 andover60kg/m2 showedcontinuousweightloss
throughouttheentire24-monthfollow-upperiod(Figure1).
Table 6 shows the BMI progression for the 57 patients
(69.5%) who did not need a second operation for fur-
ther weight loss. On average, there was a tendency
toward increased weight after 18 months in these patients
(34.0kg/m2 to 35.6kg/m2). The most signiﬁcant weight loss
was achieved within the ﬁrst postoperative year (P<0.0005)
(Table 5). Regarding the percentage overweight loss, the
highest %EWL of 68.4% occurred after 18 months, and after
24 months, there was a further %EWL of 62.6%. The highest
%EWLof83.3%wasobservedinpatientswithBMIsbetween
35 and 39.9kg/m2 after 18 months (Table 6).
3.5. Mortality Rate. Mortality rate after 24 months of total
followup is 2.4%. One patient died during hospital stay at
73rd day postoperatively, due to SIRS and ARDS. Second
patient died several months after SG due to his cardiac
situation without any relation to operation.Journal of Obesity 5
Table 5: Weight progression (BMI in kg/m2) of patients without a second operation during the follow-up period (n = 57).
Timeline (months)
BMI OP 3 6 12 18 24
35–39.9kg/m2 38.3 31.3 30.2 27.8 27.5 28.4
40–49.9kg/m2 44.0 34.7 31.5 29.4 29.3 29.9
50–59.9kg/m2 53.2 44.2 39.6 37.5 36.8 38.2
≥60kg/m2 65.6 52.5 47.0 43.5 42.1 43.7

















































Figure 1: %EWL of all of the patients during the follow-up period.
3.6. Revisional Procedures after SG. Over the total observa-
tion period of 24 months, a second operation to induce
weight loss was required in 30.5% (25) of the patients to
develop further weight loss or amelioration on comorbidi-
ties. Three patients with BMIs between 50 and 59.9kg/m2
underwent RYGBP as a second operation. The other 22
patients (26.8%) underwent DS.
3.7. Laboratory Parameters
3.7.1. Iron. Iron supplementation was performed in 42
patients (51.2%). Six of these patients experienced micro-
cytic anemia following SG, which required the initiation
of iron supplementation. All patients did not suﬀer from
iron deﬁciency before operation and were with normal
hemoglobinandironlevelspreoperatively.Inallpatientsoral
supplementation was performed with twice a day 120mg
iron. A parenteral supplementation due to the fact of severe
iron deﬁciency was not necessary in these patients. In 23
of 42 patients, iron supplementation was performed as
prophylaxis after a second operation (RYGBP or DS), and
the other 19 patients (23.2%) were supplemented after SG.
Of these 19 patients, 16 were female, and 3 were male. To
examine if iron supplementation is only necessary in fertile
women, we examined especially the data of the women.
Women had a mean age of 41.6 years (25–59). Ten of these
16 women recorded a reduced iron value, and the other 6
women were supplemented with a combination of folic acid
and iron.
3.7.2. Zinc. The highest average value for zinc 14.80µmol/L
was determined preoperatively (reference range 10–
23µmol/L). There were no signiﬁcant diﬀerences among
the average values in the follow-up period. In total,
30 patients underwent zinc supplementation, and 4 of
these complained of hair loss. Nineteen patients were
supplemented preventively because of a second operation
(RYGBP or DS) for weight loss. Eleven patients (13.4%)
were supplemented following SG due to zinc deﬁciency.
Supplementation was performed as 15mg zink daily.
3.7.3. Selenium. The highest average value for selenium
of 81.7µg/L (reference range 50–120µg/L) was determined
preoperatively. After 3 months, a signiﬁcant decrease of
60.87µg/L (P<0.0005) occurred. No other signiﬁcant
diﬀerences were observed over the course of the followup.
Due to selenium deﬁciency in laboratory eight patients
after SG were treated with selenium supplementation using6 Journal of Obesity
Table 6: %EWL of patients without a second operation during the follow-up period (n = 57).
Timeline (months)
BMI 3 6 1 21 82 4
35–39.9kg/m2 53.3 62.5 80.7 83.3 76.3
40–49.9kg/m2 49.3 65.4 76.6 78.0 74.5
50–59.9kg/m2 33.3 48.0 54.7 57.4 52.8
≥60kg/m2 30.9 45.1 53.4 59.8 53.8
Total 40.7 54.3 65.3 68.4 62.6
100µg twice a day. Among the 57 patients who did not
undergo a second operation, there was a gradual increase
in the concentration of selenium (OP: 81.6µg/L; 3rd month:
62.0µg/L; 6th month: 62.7µg/L; 12th month: 65.2µg/L; 18th
month: 66.8µg/L; 24th month: 69.7µg/L).
3.7.4. Calcium and Parathyroid Hormone. In 46 of the 82
patients, PTH levels were preoperatively determined, and
19.6% of the patients (9) had hyperparathyroidism. The
average PTH levels (reference range 10.0–69.0ng/L) for
patients with BMIs over 60kg/m2 were 81.6ng/L preop-
eratively, 67.3ng/L after 6 months and 61.9ng/L after 18
months. Thirty-one patients (37.8%) were supplemented
with calcium carbonate and cholecalciferol, including 15
patients supplemented after a second operation (RYGBP or
DS). For calcium supplementation patients got four times
daily 500mg calcium with 10µg cholecalciferol. Twenty-two
patients (26.8%) were treated with separate or additional
vitamin D supplementation due to high levels of PTH,
including 9 patients treated preventively after a second
operation for weight loss.
Under supplementation, a rising concentration of PTH
appeared 3 months after the operation. After 6 months, a
decrease in the concentration of PTH was identiﬁed. After
the 6 months, there were no signiﬁcant diﬀerences among
the PTH levels (Tables 7 and 8).
Vitamin D levels were not investigated routinely, due to
the fact that follow-up examination in metabolic surgery is
not covered by health insurance system in Germany.
3.7.5. Albumin. SG did not signiﬁcantly aﬀect the patients’
albumin levels (reference range 34.0–48.0g/L) during the
follow-up period. Only 3 patients demonstrated hypoalbu-
minemia 3 months after SG, and all 3 of these patients had
experienced intra- or postoperative complications.
3.7.6. Vitamin B12. Thirty-eight patients (46.3%) received
vitamin B12 supplementation, including 18 patients after
RYGBP or DS. For vitamin B12 supplementation 1000µg
vitamin B12 monthly was ordinated. The other 20 (24.4%)
supplemented patients were treated with supplementation
within the ﬁrst postoperative year (Table 9). Under supple-
mentation, the vitamin B12 levels achieved stable average
values (reference range 175–810pmol/L) during the entire
follow-up period.
In addition, the other 57 patients, who did not undergo
a second operation for further weight loss, demonstrated
stable and not signiﬁcantly diﬀerent vitamin B12 con-
centrations (OP: 282.7pmol/L; 3rd month: 289.6pmol/L;
6th month: 265.8pmol/L; 12th month: 260.0pmol/L; 18th
month: 256.1pmol/L; 24th month: 277.5pmol/L).
3.7.7.FolicAcid. Regardingfolicacid(referencerange10.40–
42.40nmol/L), there was a signiﬁcant decrease 3 months
after the operation from 19.82nmol/L to 15.51nmol/L (P<
0.0005). 13 patients were supplemented following SG due
to folic acid and/or iron deﬁciency with a combination
of folic acid and iron. After RYGBP or DS were regularly
supplemented 21 patients. After the third month following
the operation, an increasing concentration of folic acid was
observed as a result of supplementation, with a maximum
average level of 20.96nmol/L occurring after 24 months.
Supplementation was performed with a combination of folic
acid 0.5mg and iron 40mg daily.
4. Discussion
SG is an eﬀective operative method for inducing weight
loss. SG may be used as a single operation, or in the case
of insuﬃcient weight loss, it can be suggested as a second
operation, such as RYGBP or DS. Additionally, SG can be
performed as the ﬁrst step of a two-stage procedure for
high-risk patients to reduce the perioperative risks of DS or
RYGBP.
An analysis of the literature shows the beneﬁts of LSG
compared to laparoscopic gastric banding (LAGB) and
laparoscopic RYGBP. There are several technical advantages
of SG: nonresection of the pylorus, which prevents dumping
syndrome; no intestinal anastomoses and, consequently,
no insuﬃciencies of anastomoses; nearly regular intestinal
absorption and a lower risk of developing an internal hernia
[11].DuetohighcomplicationrateofSGprocedureisstillin
discussion. particulary short-term complications as leakage
and staple line insuﬃciency inﬂuence the complication
rate. In the literature an increasing long-term complication
rate is reported to be due to stenosis, gastroesophageal
reﬂux, and reoperation rate due to insuﬃcient weight loss,
regainofweightorinsuﬃcientameliorationofcomorbidities
[12]. Evidence-based data on nutrient deﬁciencies, especially
vitamin B12 and iron, after SG is not available.Journal of Obesity 7
Table 7: Postoperative course of calcium (mmol/L).
Timeline (months)
BMI OP 3 6 12 18 24
35–39.9kg/m2 2.36 2.33 2.37 2.40 2.40 2.44
40–49.9kg/m2 2.36 2.38 2.40 2.35 2.38 2.36
50–59.9kg/m2 2.37 2.35 2.38 2.34 2.35 2.30
≥60kg/m2 2.34 2.45 2.39 2.34 2.34 2.33
Total 2.36 2.37 2.39 2.35 2.36 2.34
Table 8: Postoperative course of parathormone (ng/L).
Timeline (months)
BMI OP 3 6 12 18 24
35–39.9kg/m2 34.70 50.67 41.98 42.68 44.70 39.90
40–49.9kg/m2 50.42 58.84 51.20 51.68 50.71 54.94
50–59.9kg/m2 46.51 45.95 50.57 54.20 54.70 56.28
≥60kg/m2 81.58 87.62 67.25 60.75 61.86 64.81
Total 55.57 59.62 53.84 53.77 54.34 56.52
RYGBP and BPD are the most eﬀective, but also the
riskiest, bariatric methods. Both procedures tend to increase
the risk of perioperative complications based on the diﬃcult
technical circumstances surrounding the patients’ weight
and the associated comorbidities, such as hypertension,
diabetes, and sleep apnea. The complication rates for super-
super obese patients are 23% for RYGBP and 38% for DS.
The mortality after RYGBP is 0.5% and 1.0% after DS [13].
SG, however, reduces perioperative risks of morbidly obese
patients with BMI above 60 as a ﬁrst step procedure.
The reported initial weight loss after SG spans a wide
range,between33and83%[14,15].Inaprospectivestudyof
100 patients, Johnston et al. presented a %EWL of 60% after
5y e a r s[ 16].
That study group achieved a %EWL of 59.1% after 12
months and 63.8% after 24 months.
Over a 24-month period, the entire patient population
experienced continuous weight loss up to the 18th month.
After 24 months a weight loss to a BMI of 35.4kg/m2 was
achieved. SG as a single operation is suitable for patients
with BMIs <50kg/m2. Only 10.3% of these patients (3/29)
required a second intervention to induce further weight
loss within the follow-up period (versus 41.5% with BMIs
≥50kg/m2).
After 24 months, patients who only underwent SG
with BMIs between 35 and 39.9kg/m2 achieved the highest
%EWL. Therefore, there was no correlation between the
resected volume of the stomach and the %EWL. Only one
patient (16.7%) needed to undergo a second operation for
further weight loss.
After 18 months, patients who only underwent SG
demonstrated increased mean weights, which may have been
due to sleeve dilatation. This possibility was considered by
Gluck et al., who presented %EWLs of 67.9% after 1 year,
62.4% after 2 years, and 62.2% after 3 years for patients after
SG with preoperative BMIs between 35 and 43kg/m2 [17].
There is not always suﬃc i e n tw e i g h tl o s sa f t e rS G ;
insuﬃcient changes in food patterns or potential recidivism
to old food patterns may cause a sleeve dilatation. One
option for treatment may be a resleeve operation. There
are inadequate data to properly appraise this option, and
further studies must clarify the utility of this procedure in
comparison to RYGBP or DS as a second operation.
In addition because of the moderate rate of major
complications of 9.8% (8/82), SG can be recommended as
a ﬁrst-step operation before malabsorptive interventions.
Regarding postoperative complications, there were no sig-
niﬁcant diﬀerences among the BMI categories. However,
patients with BMIs ≥60kg/m2 required a change to laparo-
tomy signiﬁcantly more often because of an insuﬃcient
intraabdominal view. Preoperative implantation of a gastric
balloon to reduce morbidity for patients with BMIs over
60kg/m2 still needs to be addressed.
In this study, there was a 30-day mortality of 0.0%, a
hospitalization mortality of 1.2%, and a one-year mortality
of 2.4%.
There were 2 patients who did not beneﬁt from SG.
One patient with a preoperative BMI of 50.5kg/m2 ﬁrst lost
weight after SG, but his weight eventually increased to a
higher level than before SG (59.7kg/m2 by the end of the
followup).Aninsuﬃcientchangeinfoodpatternsandintake
of high-calorie foods appeared to be the cause. The other
patient, with a preoperative BMI of 55.5kg/m2, died after a
prolonged course with various complications on day 73 after
SG.
One other severe obese patient with a preoperative BMI
of 68.0kg/m2 died 10 months postoperatively. A causal8 Journal of Obesity
Table 9: Necessity of vitamin B12 supplementation during the follow-up period.
BMI
35–39.9kg/m2 40–49.9kg/m2 50–59.9kg/m2 ≥ 60kg/m2 Total
Vitamin B12 n % n % n % n % n %
A f t e r O P 00 . 000 . 000 . 015 . 61 1 . 2
After 3 months 1 16.7 4 17.4 5 14.3 1 5.6 11 13.4
After 6 months 0 0.0 1 4.3 4 11.4 1 5.6 6 7.3
A f t e r 1 2 m o n t h s 00 . 014 . 300 . 015 . 62 2 . 4
A f t e r 1 8 m o n t h s 00 . 000 . 000 . 000 . 00 0 . 0
A f t e r 2 4 m o n t h s 00 . 000 . 000 . 000 . 00 0 . 0
After 2nd OP 1 16.7 2 8.7 10 28.6 5 27.8 18 22.0




with a mortality of 1.2% and a nonresponder rate of 1.2%.
Twenty-ﬁve patients (30.5%) in this study required a
second operation via a two-stage procedure for further
weight loss.
Nutritional deﬁcits after LSG are rarely evaluated. In
postoperative course there is no suggestion for vitamin
supplementation. Evidence-based data on necessity of sup-
plementation after SG does not exist in the literature. After
evaluating nutritional deﬁciencies, there is no need for
supplementation after SG, although preoperative existing
deﬁcits should be supplemented. Laboratory parameters
should be monitored regularly to detect early nutritional
deﬁciencies and to initiate appropriate therapies.
VitaminB12levelswereinthelowerthirdofthereference
range without supplementation. Therefore, it is likely that,
without supplementation, vitamin B12 deﬁciencies can
occur, especially more than two years after operation due to
empting ofvitaminB12storage.Therefore,ageneralvitamin
B12supplementationisadvisabletoavoidperniciousanemia
and to prevent neuropathic pain.
Patients with deﬁciencies in albumin, vitamin D, or cal-
ciumhaveahigherriskofdevelopingosteoporosis;therefore,
it is recommended that appropriate supplementations be
initiated, even if the concentrations of these parameters are
only slightly decreased. PTH levels should be determined to
diagnose secondary hyperparathyroidism.
Based on to parameters, iron supplementation should
be initiated similar to the supplementation of folic acid.
Moreover, supplementation of zinc should be based on
symptoms (hair loss, immune deﬁciency, dry skin). High
zinc intake reduces absorption of copper and iron and vice
versa. Medication of zinc and calcium should be suggested
to intake at diﬀerent times, because zinc reduces calcium
absorption. Supplementation of selenium is not generally
necessary because postoperative deﬁciencies normalize on
their own without supplementation, and an adequate, varied
food intake seems to be suﬃcient.
Regular determination of laboratory parameters should
be performed 3 and 6 months after the operation and
semiannually thereafter; if the patient’s weight stabilizes,
laboratory parameters should be determined once a year.
5. Conclusion
Our results following SG and those reported in the literature
are promising. Nevertheless, adequate long-term results are
still unavailable because long-term studies (>6y e a r s )a r e
rarely performed.
The eﬀectiveness and safety of SG are encouraging.
The operative treatment is not comparable among
studies because of a lack of standardization [9]. Also, the
3rd ICSSG could not recommend which part of the antrum
should be left and to what degree the antrum should be
minimized to achieve a long-term volume reduction in the
sleeve[18].Additionally,evidence-baseddataareunavailable
concerning the size of the bougie or whether the use of staple
line reinforcement could reduce the rates of leakage [19].
Good results are not only based on the operation being
performed in a center for bariatric surgery; the patients’
instructions from dietitians are at least as important.
The conditions for excellent results are patient compli-
ance, an adequate change in lifestyle and food patterns, and
regular aftercare in obesity consultation to optimize results,
and detect nutritional deﬁciencies promptly. SG represents
a good possibility as a single-step operation for surgically
induced weight loss with a high patient acceptance rate. A
second step for further weight loss can follow.
6. Summary
(1) SG is an eﬀective intervention for weight loss. For
patients with BMIs of 35–49.9kg/m2, a single-step
procedure is suitable. For patients with BMIs ≥
50kg/m2, SG is suitable as a ﬁrst-step procedure for
reducing perioperative risks for DS [20].
(2) There is still no consensus on the use of staple line
reinforcements or the size of the calibration tubes.
(3) For patients with BMI above 60kg/m2,p r e o p e r a t i v e
implantationofagastricballoonshouldbediscussed.
Studies on this issue are necessary for reducing
morbidity and mortality.Journal of Obesity 9
(4) There was no correlation between the %EWL and the
resected gastric volume.
(5) Supplementation of vitamin B12 is indicated and
should generally be initiated after SG.
(6) Supplementation of iron and folic acid should
depend on laboratory parameters for both genders.
(7) A deﬁciency in albumin was not reproducible in our
patients.
(8) Supplementation of zinc should be based on symp-
toms.
(9) Substitution of selenium is not necessary.
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